Results 161 to 170 of about 463,138 (331)

Bacteriophages and their structural organisation [PDF]

open access: yes, 2012
Viruses are extremely small infectious particles that are not visible in a light microscope, and are able to pass through fine porcelain filters. They exist in a huge variety of forms and infect practically all living systems: animals, plants ...
Orlova, Elena
core   +2 more sources

Thiolated Hyaluronic Acid: A Gateway for Targeted Killing of Staphylococcus aureus on the Race for Surface Colonization

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 2, 14 January 2026.
Thiolated hyaluronic acid (HAMS) synthesized and characterized by NMR, solubility, thiol content, and pKa, is degraded by Staphylococcal hyaluronate lyase but not by mammalian hyaluronidase. Coating polyphosphate–M23 phage endolysin nanoparticles (M23‐PP) with HAMS confers Staphylococcus aureus responsiveness.
Mariana Blanco Massani   +11 more
wiley   +1 more source

Virus Enhanced Microrobots for Biofilm Eradication

open access: yesAdvanced Materials, Volume 38, Issue 2, 8 January 2026.
Biofilms resist antimicrobials across medicine, industry, and environments. We present virus‐conjugated microrobots synthesized hydrothermally and magnetically actuated. Their motion and viral specificity enable targeted binding, penetration, and delivery, outperforming bare microrobots.
Jyoti   +3 more
wiley   +1 more source

Probiotic‐Based Materials as Living Therapeutics

open access: yesAdvanced Materials, Volume 38, Issue 1, 2 January 2026.
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio   +2 more
wiley   +1 more source

Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus

open access: yesBMC Microbiology, 2009
Background Bacteriophages can be successfully applied to treat infections caused by antibiotic-resistant bacteria. Until now no attempts have been undertaken to treat infections in immunosuppressed patients with phages.
Borysowski Jan   +5 more
doaj   +1 more source

Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant Staphylococcus aureus

open access: yesACS Applied Materials & Interfaces
The increasing prevalence of bacterial multidrug antibiotic resistance has led to a serious threat to public health, emphasizing the urgent need for alternative antibacterial therapeutics. Lytic phages, a class of viruses that selectively infect and kill bacteria, offer promising potential as alternatives to antibiotics.
Yajing Xu   +5 more
openaire   +2 more sources

Activity and Characteristics of a New Staphylococcus Phage 94

open access: yesExperimental Biology and Medicine, 1973
SummaryStaphylococcus phage 94, formerly designated WH-1, was found to type 119 (13.2%) of 900 clinical isolates which were untypable with the basic series of typing phages. Strains typed by this phage were uniformly resistant to penicillin, ampicillin, and colymycin. A lytic spectrum for phage 94 is presented and the phage is shown to be antigenically
L E, Blouse   +3 more
openaire   +2 more sources

The Importance of Being Imperfect: Structure and Function of Bacterial Amyloid

open access: yesAdvanced Science, Volume 13, Issue 4, 19 January 2026.
Functional bacterial amyloids such as CsgA and FapC have been widely studied to understand the relationship between aggregation and function. The recently solved structure of FapC reveals a Greek‐key motif in which extensive hydrogen bonding and packing interactions formed by residues in conserved imperfect repeats stabilize a β‐solenoid core.
Samuel Peña‐Díaz   +12 more
wiley   +1 more source

Vancomycin‐Functionalized Nanodelivery Systems for Antibacterial Tissue Engineering Scaffolds

open access: yesAdvanced NanoBiomed Research, Volume 6, Issue 1, January 2026.
This review consolidates recent advancements in VAN nanoformulations, critically evaluating their design principles, release mechanisms, and efficacy profiles against resistant Gram‐positive pathogens. While promising in vitro and in vivo results have been demonstrated, the clinicaltranslation of these technologies necessitates further rigorous ...
Nima Beheshtizadeh   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy